Company Overview

Our Team

Employment Opportunities'; } ?>



Photograph of the counterpulsation device and an illustration indicating how the device is connected to a patient's heart.
The chronic implantable counterpulsation device.

SCR Inc. was founded in 1997 by Paul A. Spence, M.D., a cardiothoracic surgeon with extensive clinical, research and entrepreneurial experience. Initially, SCR worked with researchers at the University of Louisville and the Cardiovascular Innovation Institute to develop and complete NIH-supported acute efficacy studies for its chronic implantable counterpulsation device. Today, SCR has expanded its scope and is developing a number of cardiovascular devices, each on the path toward clinical trials.